1 patent quality initiatives biotechnology/chemical/pharmaceutical customer partnership tuesday,...
TRANSCRIPT
![Page 1: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/1.jpg)
1
Patent Quality InitiativesBiotechnology/Chemical/Pharmaceutical Customer Partnership
Tuesday, April 7, 2015
Valencia Martin-WallaceDeputy Commissioner for Patent Quality
![Page 2: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/2.jpg)
2
World-Class Patent Quality System
The Right Time for a Greater Focus on Quality
• America Invents Act (AIA) provides a stable budget to pursue quality initiatives
• USPTO continues to reduce patent application inventory and pendency
• IT and other resource improvement initiatives support our employees
• Enhancing patent quality is a priority
![Page 3: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/3.jpg)
3
Internal Steps to Improve Patent Quality
• Fall 2014 - Gathered valuable ideas from USPTO – focus groups made up of a cross section of employees
• Issued updated examiner guidance following court rulings
• Increase in training
• Patent Quality Forums held with Patents employees– March 11 and March 24, 2015
![Page 4: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/4.jpg)
4
Internal Steps to Improve Patent Quality (continued)
• Increased resources to improve patent examination quality
• Compare best practices and collaborate with foreign counterpart offices to improve quality
• Research and consider leveraging data analytics to improve the examination process
![Page 5: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/5.jpg)
5
External Steps Toward Improving Patent Quality
• Understanding Our Stakeholder’s Perspective– What does quality mean to IP stakeholders?
• Discuss current quality measure – Collect and analyze feedback – Re-evaluate current measures
• Public comments requested through Federal Register notice
![Page 6: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/6.jpg)
6
Patent Quality Summit
– Held March 25 – 26, 2015– Alexandria, VA Headquarters– Excellent attendance and participation for both days of the Summit– Stakeholder Discussion on the Importance of Quality
• Speakers from various Intellectual Property Industries• All audience discussion
– Discussed Proposals to Enhance Patent Quality
![Page 7: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/7.jpg)
7
I. Excellence in work products1. Applicant requests prosecution review of selected applications2. Automated pre-examination search3. Clarity of the record
II. Excellence in measuring patent quality1. Review/improvements to quality metrics
III. Excellence in customer service1. Review of current compact prosecution model and effect on quality2. In-person interview capability with all examiners
Patent Quality Summit
![Page 8: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/8.jpg)
8
Patent Quality Summit
Emerging themes among the participants included:• Providing a clear record throughout prosecution• Differentiating between the measures of the patent process and the
patent product• The usefulness (necessity) of face-to-face interviews
![Page 9: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/9.jpg)
9
PROPOSAL 1Applicant Requests for Prosecution
Review of Selected Applications
![Page 10: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/10.jpg)
10
PROPOSAL 2Automated Pre-Examination Search
![Page 11: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/11.jpg)
11
PROPOSAL 3Clarity of Record
![Page 12: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/12.jpg)
12
PROPOSAL 4Review of and Improvements to Quality Metrics
![Page 13: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/13.jpg)
13
PROPOSAL 5Review of the Compact Prosecution Model
and the Effect on Quality
![Page 14: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/14.jpg)
14
PROPOSAL 6In-Person Interview Capability
with All Examiners
![Page 15: 1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner](https://reader035.vdocument.in/reader035/viewer/2022072013/56649e4c5503460f94b4161d/html5/thumbnails/15.jpg)
15
Next Steps
• As we move ahead over the next several months we have several next steps planned:
– Posting a video of the Summit on the web for you to access and review
– Federal Register notice comment period runs through May 6, 2015
– Submit your comments and ideas responsive to the FR Notice to [email protected] email box
– Road shows later in the summer